Dr. Richard E. Fine, MD, FACS presents the technology and techniques behind breast tumor cryoablation using the liquid nitrogen (LN2) based ProSense System. In this webinar, Dr. Fine presents an in-depth look at the positive interim results of the landmark ICE3 clinical trial on cryoablation of small, low-risk breast cancers.
Webinar participants will:
- Learn about the technology and techniques behind Liquid Nitrogen (LN2) based cryoablation with the ProSense™ System
- Understand patient benefits of cryoablation
- Get updated ICE3 clinical trial interim results.